Defining the transcriptional regulation of the intestinal sodium-glucose cotransporter using RNA-interference mediated gene silencing

Surgery. 2008 Aug;144(2):168-73. doi: 10.1016/j.surg.2008.03.010. Epub 2008 May 9.

Abstract

Background: The sodium glucose cotransporter (SGLT1) is responsible for all active intestinal glucose uptake. Hepatocyte nuclear factors 1 alpha and beta (HNF 1 alpha and HNF 1 beta) activate the SGLT1 promoter, whereas GATA-binding protein 5 (GATA-5) and caudal-type homeobox protein 2 (CDX2) regulate transcription of other intestinal genes. We investigated SGLT1 regulation by these transcription factors using promoter studies and RNA interference.

Methods: Chinese hamster ovary (CHO) cells were transiently cotransfected with an SGLT1-luciferase promoter construct and combinations of expression vectors for HNF 1 alpha, HNF 1 beta, CDX2, and GATA-5. Caco-2 cells were stably transfected with knockdown vectors for either HNF 1 alpha or HNF 1 beta. mRNA levels of HNF 1 alpha, HNF 1 beta, and SGLT1 were determined using quantitative polymerase chain reaction (qPCR).

Results: HNF 1 alpha, GATA-5, and HNF 1 beta significantly activated the SGLT1 promoter (P < .05). Cotransfection of GATA-5 with HNF 1 alpha had an additive effect, whereas HNF 1 beta and CDX2 antagonized HNF 1 alpha and GATA-5. SGLT1 expression was significantly reduced in HNF 1 alpha or HNF 1 beta knockdowns (P < .001). HNF alpha knockdown significantly reduced HNF 1 beta expression and vice versa (P < .005).

Conclusions: HNF 1 alpha and HNF 1 beta are important transcription factors for endogenous SGLT1 expression by cultured enterocytes. GATA-5 and CDX2 also regulate SGLT1 promoter activity and show cooperativity with the HNF1s. We, therefore, propose a multifactorial model for SGLT1 regulation, with interactions between HNF1, GATA-5, and CDX2 modulating intestinal glucose absorption.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CDX2 Transcription Factor
  • CHO Cells
  • Caco-2 Cells
  • Cricetinae
  • Cricetulus
  • GATA5 Transcription Factor / antagonists & inhibitors
  • GATA5 Transcription Factor / pharmacology
  • Gene Expression Regulation
  • Gene Silencing*
  • Hepatocyte Nuclear Factor 1-alpha / metabolism
  • Hepatocyte Nuclear Factor 1-alpha / pharmacology
  • Hepatocyte Nuclear Factor 1-beta / antagonists & inhibitors
  • Hepatocyte Nuclear Factor 1-beta / metabolism
  • Hepatocyte Nuclear Factor 1-beta / pharmacology
  • Homeodomain Proteins / pharmacology
  • Humans
  • Promoter Regions, Genetic / drug effects
  • RNA Interference*
  • Sodium-Glucose Transporter 1 / genetics
  • Sodium-Glucose Transporter 1 / metabolism*
  • Transcription, Genetic*
  • Transfection

Substances

  • CDX2 Transcription Factor
  • CDX2 protein, human
  • GATA5 Transcription Factor
  • Hepatocyte Nuclear Factor 1-alpha
  • Homeodomain Proteins
  • Sodium-Glucose Transporter 1
  • Hepatocyte Nuclear Factor 1-beta